Traws Pharma, Inc. — Investor Relations & Filings
Filings indexed
932
across all filing types
Latest filing
2026-05-29
Annual Report
Country
US
United States of America
Listing
US
TRAW
Traws Pharma, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel oral small-molecule therapies for respiratory viral diseases. The company focuses on advancing investigational antiviral agents with potent activity against difficult-to-treat or resistant virus strains. Its pipeline includes two lead candidates: ratutrelvir, a ritonavir-independent antiviral targeting the Main protease (Mpro) for the treatment of COVID-19 and Long COVID, and tivoxavir marboxil, a single-dose antiviral targeting the influenza cap-dependent endonuclease (CEN) for the treatment and prevention of bird flu and seasonal influenza. The company aims to develop safe product candidates with simple dosing regimens.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS | 2026-05-29 | English | |
| DEFA14A | 2026-05-29 | English | |
| DEF 14A | 2026-05-29 | English | |
| FORM 8-K | 2026-05-27 | English | |
| FORM 8-K | 2026-05-26 | English | |
| 424B5 | 2026-05-22 | English |
Browse filings by year
23 years- 2026 19 filings
- 2025 92 filings
- 2024 73 filings
- 2023 40 filings
- 2022 39 filings
- 2021 79 filings
- 2020 70 filings
- 2019 99 filings
- 2018 99 filings
- 2017 47 filings
- 2016 88 filings
- 2015 52 filings
- 2014 40 filings
- 2013 76 filings
- 2012 3 filings
- 2011 1 filing
- 2010 2 filings
- 2009 1 filing
- 2007 2 filings
- 2006 2 filings
- 2005 2 filings
- 2004 2 filings
- 2003 4 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47887424 | ARS | 2026-05-29 | English | ||
| 47886670 | DEFA14A | 2026-05-29 | English | ||
| 47886705 | DEF 14A | 2026-05-29 | English | ||
| 47571798 | FORM 8-K | 2026-05-27 | English | ||
| 47073394 | FORM 8-K | 2026-05-26 | English | ||
| 46816511 | 424B5 | 2026-05-22 | English | ||
| 46363212 | 424B3 | 2026-05-15 | English | ||
| 46352924 | 10-Q | 2026-05-15 | English | ||
| 46352907 | FORM 8-K | 2026-05-15 | English | ||
| 44433492 | S-3 - Traws Pharma, Inc. (0001130598) (Filer) | 2026-05-08 | English | ||
| 34610821 | 10-K - Traws Pharma, Inc. (0001130598) (Filer) | 2026-04-15 | English | ||
| 34609866 | 8-K - Traws Pharma, Inc. (0001130598) (Filer) | 2026-04-15 | English | ||
| 34577213 | 8-K - Traws Pharma, Inc. (0001130598) (Filer) | 2026-04-15 | English | ||
| 32888113 | 8-K - TRAWS PHARMA, INC. (0001130598) (Filer) | 2026-02-19 | English | ||
| 28061771 | SCHEDULE 13G Filing | 2026-02-12 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Biosynex
Designs and distributes medical diagnostic solutions, inclu…
|
ALBIO | FR | Manufacturing |
|
BioSyntech, Inc.
Develops advanced biotherapeutic thermogels for tissue repa…
|
BSYI | CA | Manufacturing |
|
BIO-TECHNE Corp
Global supplier of reagents and instruments for research an…
|
TECH | US | Manufacturing |
|
Bioten Co., Ltd
Develops and manufactures natural health foods, cosmetics, …
|
289170 | KR | Manufacturing |
|
Biotest AG
Develops and supplies plasma protein products and biotherap…
|
BIO3 | DE | Manufacturing |
|
Bio-Thera Solutions, Ltd.
Develops innovative therapeutics and biosimilars for oncolo…
|
688177 | CN | Manufacturing |
|
Biotika A.S.
A biotechnology company that manufactures APIs for human an…
|
BSL | SK | Manufacturing |
|
Bioton S.A.
A global manufacturer of recombinant human insulin and diab…
|
BIO | PL | Manufacturing |
|
BIOVENTIX PLC
Develops and supplies sheep monoclonal antibodies for clini…
|
BVXP | GB | Manufacturing |
|
Bioversys N
Clinical-stage biopharma developing antibacterial therapies…
|
BIOV | CH | Manufacturing |
Traws Pharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35199/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35199 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35199 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35199 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35199}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Traws Pharma, Inc. (id: 35199)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.